The “Marijuana Legislation Company”, aka Freedom Leaf Inc., is a provider of cannabis centered multi-media news and entertainment. Operating from its print publication, Freedom Leaf Magazine, and website, www.freedomleaf.com, the company promotes the legalization of marijuana while aligning itself with the industry’s successes. To take an active role in this movement, Freedom Leaf intends to disperse its magazine to non-profit groups and the individual in hopes of increasing cannabis awareness.

One of the non-profits the company supports is NORML, the National Organization for the Reform of Marijuana Laws. Founded in 1970, this group’s mission is to move public opinion enough to legalize the responsible use of marijuana by adults. NORML is an advocate for safe, high-quality marijuana for consumers and therefore offsets anti-marijuana propaganda.

The other non-profit Freedom Leaf supports is SSDP, Students for Sensible Drug Policy, an international network of students devoted to finishing the war on drugs. The only international group of its kind, SSDP brings young people together in order to discuss drugs and drug policy in an honest environment. Since its creation in 1988, the non-profit has gained thousands of members from all over the world.

Freedom Leaf disperses its magazine to these two non-profits for free. Not only that, but the company now welcomes individuals to help disperse its publication on their own. People are allowed to buy the magazine in groups of 45 or 85 while just paying the shipping and processing fees. These clients can then sell the magazine to their communities for cannabis news and education.

The company states that its publications are “designed to empower a network of activists in the United States and around the world.” By granting other people with the same views access to market this magazine, Freedom Leaf is widening its coverage and demographic.

For more information, visit the company’s website at http://freedomleaf.com

Let us hear your thoughts: Freedom Leaf Inc. Message Board

In a news release earlier today, GTX Corporation announced its financial results for the fiscal quarter ended September 30, 2015. The company’s efforts to expand upon its existing distribution channels and build pivotal strategic alliances resulted in favorable short-term gains, as it recorded a 189 percent year-over-year increase in total revenues alongside a 169 percent decrease in total expenses. In total, GTXO added three European countries to its distribution list during the quarter and signed a pivotal global connectivity agreement with Telefonica (NYSE: TEF), one of the largest telephone operators and mobile network providers on the planet.

For the remainder of 2015, GTXO plans to continue implementing its broadened growth strategy in an effort to increase sales in all three of its product categories – including embedded, stand alone and digital tracking and monitoring solutions. The company’s GPS SmartSole® product, in particular, is expected to provide a strong channel for industry growth in the coming months. GTXO finalized development of the next-generation monitoring platform in the third quarter, and commercial release is currently scheduled for early 2016.

With its innovative GPS SmartSole products, GTXO is already making waves in a wearable technology market that’s currently led by major tech firms such as Microsoft (NASDAQ: MSFT) and Samsung (OTC: SSNLF). At CTIA’s Super Mobility Awards, GPS SmartSole finished second for its revolutionary approach to location monitoring, as well as its potential to address a critically underserved need in the medical community in regard to people afflicted with cognitive memory disorders such as Alzheimer’s, dementia, autism and traumatic brain injury.

According to a report by the Alzheimer’s Association, roughly six in 10 people with dementia will wander, potentially putting themselves in serious danger should they become disoriented. Although 94 percent of individuals who wander are found within 1.5 miles of where they were last seen, many are unable to recall their names and addresses. As a result, loved ones are tasked with locating these individuals and returning them to safety in a timely manner. GTXO’s GPS SmartSole minimizes the risk associated with these incidents by providing real-time tracking services that fit easily into most adult shoes.

As GTXO continues to advance toward establishing a global subscriber base with its revolutionary next-gen technologies, the company is in a strong position to build on its recent financial performance throughout the remainder of 2015 and into the future. GTXO’s short-term goals include continuing to expand distribution channels, reaching out to broader market segments, increasing brand and product awareness and, ultimately, maximizing its global subscriber base.

“Together, these initiatives underwrite our corporate mission to build a best in class solution for the millions of people all over the world who need a simple, affordable and effective tracking and monitoring solution,” Patrick Bertagna, chief executive officer of GTXO, stated in the news release.

For more information about GTX Corporation, visit www.gtxcorp.com/

Let us hear your thoughts: GTX Corp. Message Board

Unlike the United States, China currently boasts several social networks with more than 100 million active users. These platforms serve a collection of different purposes ranging from messaging and video sharing to blogging and ecommerce, and this diversity of usage creates an opportunity for new entrants with a unique commerce or communications offering to gain market share despite the existence of established competitors.

In 2014, the China Internet Network Information Center reported that there were roughly 618 million internet users throughout the Asian nation, representing a penetration rate of approximately 46 percent. Among these internet users, over 90 percent have a social media account. For comparison, just 67 percent of U.S. internet users engage in social media. However, the opportunity in China extends beyond the ability to reach a large target audience. According to the Data Center of China Internet, 38 percent of users claim they are more likely to buy items recommended by other social media users.

Moxian, Inc. is attempting to capitalize on these favorable market conditions by developing an innovative social commerce platform targeting the expansive Chinese market. Moxian+ will allow retailers and consumers to trade, communicate and locate goods and services while simultaneously being guided through the use of sophisticated, data-driven marketing techniques. Moxian plans to deploy its commerce platform in major metropolitan areas of China, Singapore and Malaysia by the end of the year.

Following its official launch, the Moxian+ platform is expected to be a comprehensive tool targeting the specific needs of brick-and-mortar businesses with internet and mobile-enabled business intelligence. While the platform will primarily connect and promote interaction of businesses and consumers online, it will also promote improved interaction across a full range of traditional sales channels.

Moxian+ is expected to serve as a sustainable source of revenue for Moxian, as the company will utilize advertising and membership fees in exchange for its services. While the majority of merchants are expected to subscribe to a basic program with a flat monthly fee, the platform will also be capable of addressing more complex requirements in exchange for additional fees commensurate with the value-added benefits.

For prospective shareholders, Moxian’s efforts to break into the expansive social networking and ecommerce markets of China could foreshadow an opportunity for the company to promote strong financial growth for the foreseeable future. Look for Moxian to continue progressing toward the official launch of Moxian+ in the weeks to come.

For more information, visit http://ir.moxian.com/html-en/

Let us hear your thoughts: Moxian, Inc. Message Board

When Giggles N’ Hugs opened its first location over five years ago, it was steadfast in its desire to offer a truly unique family restaurant concept while giving mom and dad a breather while shopping at the same time. Promoting a healthy menu and surroundings aimed to captivate and meet the needs of children, the company is well on its way to cornering a very lucrative niche for its shareholders. As of today, GIGL owns and operates three locations in greater Los Angeles, and it’s currently engaged in talks with some of the largest mall owners to expand its presence going forward.

The franchise business model could also result in an additional boost to the company’s promising growth potential should company management decide to pursue the strategy. In a recent news release, Joey Parsi, Chief Executive Officer said the company has received substantial interest from both large multi-unit franchising operators and individual franchisees regarding both domestic and international opportunities.

The company’s healthy menu continues to be one its most sustaining characteristics. High-quality organic food within a kid-friendly, casual dining area for adults featuring a huge play area is the model Giggles N’ Hugs has been successfully executing on. Parents can relax while their children get the kind of food their growing bodies need while enjoying the themed play areas. Giggles N’ Hugs is getting great reviews from its customers and mall owners at all of its L.A. locations. And don’t be surprised to see a Hollywood celebrity with their children enjoying the organic cuisine and relaxing environment!

For more information, visit www.gigglesnhugs.com

Let us hear your thoughts: Giggles ‘N Hugs, Inc. Message Board

Legacy Ventures International Inc. is a distributor of innovative food and beverage products all across North America. Through its subsidiary, RM Fresh Brands, the company seeks out high potential companies with the intent of helping them grow. In turn, shareholders are able to participate in the opportunities, revenues, and profits generated by Legacy Ventures and its subsidiaries.

The company has quite a few interests that focus on the health and food industry. Since health awareness will continue to grow, Legacy Ventures and RM Fresh Brands have brought in a couple of brands that promote drinking healthy beverages like water. More and more people are choosing bottled water over carbonated drinks to improve their health, making the industry very lucrative. Another reason for rapid growth of bottled water is the shortage of safe drinking water around the world. Consumption of 500ml of bottled water has increased 140% globally.

Furthermore, drinking bottled water is becoming a status symbol. According to marketresearchers.com, Millenials and GenXers are starting to make drinking still water a fashion accessory by carrying designer bottles. Even bottled water with flavor and mineral enhancements are fashion statements. Marketresearchers suggests companies use these factors as a marketing strategy to increase revenue streams.

Boxed Water, a company under RM Fresh Brands, caters to the designer water bottle fad by introducing a new look to the old favorite. Its water comes in a mostly paper container that is recyclable, renewable, and eco-friendly. Similarly, Aloe Gloe water contains vitamins, minerals, antioxidants, and other health benefits at just 35 calories. This water comes in pulp, pulp-free, and white grape flavors, satisfying those who are looking for a little more taste in their water.

Market researchers also suggested that those who buy bottled water are more likely to purchase organic and locally grown foods, making the other health-conscious products housed by Legacy Ventures even more likely to become profitable. By lending an ear to market trends, the company and its subsidiaries are likely to reap the rewards.

For more information, visit the company’s website at www.legacyventuresinc.com

Let us hear your thoughts: Legacy Ventures International, Inc. Message Board

Cherubim Interests issued a press release announcing that multiple major debt holders of CHIT have agreed to convert USD $506,806.96 of debt currently on the balance sheet to Series B Convertible Preferred Stock at a price of $2.50 per share. According to the release, these supporters have been invested in the company for some time now and were pleased to show additional support.

“By cleaning up the balance sheet and creating equity for the company, we are delivering on our promise to shareholders to make bold and significant improvements to our bottom line,” stated Cherubim Interests CEO Patrick Johnson. “By eliminating over a half-million dollars in debt, the Company passes an important milestone on its journey toward meeting the $4 million shareholder equity threshold, which in turn helps in achieving all qualifications for listing on the NYSE Markets. This is just one of several important, strategic financial transactions that will enhance the Company’s position going forward.”

For more information, visit www.cherubiminterests.com

Let us hear your thoughts: Cherubim Interests, Inc. Message Board

In its 20-year history OurPet’s Company has successfully rafted through its fair share of turbulence and placid waters, and today enjoys a position that evidences its canny ability to foster both innovation and corporate growth in the $71.3 billion pet products and services industry. A quick glance at what’s going on in this booming market shows why the company’s consistent sustainability is of vital importance at this particular moment.

Many experts contend that 2015 is on track to become a record setting year for global M&A activity, with takeover deals tallied in the trillions. A handful of numerous announced mega deals include Shell’s (NYSE: RDS-A) $81.5 billion purchase of British energy supplier BG Group; Charter Communication’s (NASDAQ: CHTR) $79.6 billion buyout of Time Warner Cable (NYSE: TWC); the $62.2 billion merger between Hienz and Kraft Foods – now the Kraft Heinz Company (NASDAQ: KHC); AB inBev’s $121 billion takeover of SAB Miller; and Anthem’s (NYSE: ANTM) $55.2 billion acquisition of Cigna (NYSE: CI), which is just one of many big deals in the healthcare industry this year.

Another M&A deal on deck brings us back to the pet products and services industry. Petco Holdings, which operates about 1,300 stores nationwide, is now in the limelight as two private equity-led suitors gear up to bid more than $4 billion for the No. 2 pet supply chain, reports the New York Post.

According to The Post, this puts Petco for sale at less than 10 times the company’s $480 million annual EBITDA; it’s noteworthy that buyout firm BC Partners paid $8.7 billion, roughly nine times EBITDA, for the better-performing PetSmart (NASDAQ: PETM) last year.

While large-cap deals with billions in the mix certainly dominate the headlines, the M&A activity – along with its strengthening position in the pet-supply industry and the ongoing interest in – reinstates for OurPet’s a beacon of potential as an acquisition target in the future. For the time being, the Petco and PetSmart deals represent the vast opportunities in the growing pet products and services industry.

OurPet’s develops, produces and markets various innovative pet accessory and consumable products. The company has 160 patents/patents pending, which facilitate its entrance into major national retailers, including Petco and PetSmart, Amazon (NASDAQ: AMZN), and many more. You can view the full list here http://www.ourpets.com/where-to-buy-our-products/.

Transitioning from a small-sized to medium-sized company has been no easy feat for OurPet’s though the company has adroitly managed to do so as it builds its offerings of award-winning, innovative products. OurPet’s operates two unique brands to anchor a spot in both the pet specialty and food/drug/mass market channels. The OurPet’s brand caters to pet specialty consumers while the Pet Zone brand focuses on the latter market.

With this business model, the company has steadily increased revenues – recording full-year 2014 sales of $22.7 million, $21.5 million in 2013, $20.1 million in 2012, and $19.6 million in 2011- driven by sales of its innovative pet specialty products. Side Note *Demonstrating an impressive level of transparency for an OTC stock, OurPet’s has posted nine years of well-presented annual reports on its website here: http://www.ourpets.com/upkeep/annual-report/.

The company most recently reported third-quarter results with quarterly revenue of nearly $6.0 million and an increase of 428% in net income to $410,450. Year-to-date, OurPet’s has increased revenue 6% to $17.1 million, and though the company stops short of issuing any full-year guidance, these results potentially putting it on track to maintain its four-year annual sales growth pattern.

OurPet’s key executives recently interviewed with MissionIR (listen to the interview here http://OPCO.MissionIR.com/interview.html) to discuss the company’s operations, how it plans on leveraging its innovations to sustain its growth in the pet products and services industry, existing partnerships around the world, and upcoming announcements with corporations in Japan.

Perhaps most importantly, taking into consideration the robust global M&A environment and current attention on the pet products and services industry, is company co-founder and CEO Dr. Steven Tsengas’ statement that the company plans to “grow double to triple the industry growth.”

Though its brand recognition is lesser than its large-cap peers, OurPet’s is definitely worth putting on your radar as a long and/or short-term investment consideration. For now, keep your eyes on the impending Petco purchase to see what the industry hype is all about and for a glimpse of what the future could hold for OurPet’s.

For more information visit www.ourpets.com

Analysis of the overall construction market by Washington, D.C.-based transportation infrastructure investment concern, the American Road and Transportation Builders Association (ARTBA), shows a solid rebound in previously declining public construction expenditure starting sometime back in 2013. This looks like a lagging, but mirrored expression of the now sustained 48 percent or greater rebound in the $700 billion private construction market that began back in 2011, with public construction expenditures up over 6.5 percent during 2014 to around $277 billion. The transportation segment was the biggest winner for public construction expenditures at around eight percent growth and ARTBA’s industry forecast for 2015 sees rail as the clear winner moving forward with over 14 percent projected growth, even though it represents only around a third of pavement expenditures (slated to grow 2.2 percent), or two thirds of what is spent on bridges and tunnels (forecast to grow 1.6 percent).

The heavy-civil construction market is particularly interesting here for investors, with substantial ongoing lift and earthmover heavy equipment costs, as well as a difficult-to-navigate world of contract acquisition, creating significant constraints for the big boys, and the smaller, less adroit companies as well. BLS Producer Price Index data analyzed by ARTBA further indicates that concrete and asphalt prices are set to steadily rise moving forward, meaning that maximum profitability will fall to those within the sector who are capable of exploiting connections or in-house sourcing in order to keep margins tight. In such an environment, big name heavy-civil construction operators like California-based Tutor Perini (NYSE: TPC) may increasingly find themselves on a difficult footing when going up against competitors like storied industry giant, Granite Construction (NYSE: GVA), which has at its disposal a sizeable construction materials production segment, in addition to its heavy-civil and other infrastructure operations.

These underlying sector dynamics really throw a bright spotlight on a considerably more share price-accessible company like Sterling Construction Company (NASDAQ: STRL), which has an impressive six decades plus track record of successes executing a wide variety of complex municipal, structural, transportation, water and specialty infrastructure projects via its family of companies. In addition, STRL produces asphalt, as well as aggregates from a quarry the company leases. A solid operational history over so many years in key markets across the U.S. that are noteworthy for their strong infrastructure spending, as well as a superb fleet of modern construction equipment, have helped STRL layer up a consistently expanding project backlog, securing choice contracts ahead of even the company’s larger competitors.

The latest such example was the $14 million award of a project last month by the Hawaii Department of Transportation, following up on a streak of successful smaller safety improvements the company did for HDOT on the King Kamanhameha Highway. This time around, STRL’s Road and Highway Builders subsidiary will be cold milling and paving a ten mile stretch of the highway, in addition to handling the reconstruction of four bridges, and the company expects to kick off the project as early as next quarter. The Kamanhameha contract is just the latest in a nice string of projects the company has landed this year, including the $26.3 million project award in late July from the Harris County Toll Road Authority in Houston, Texas – one of the company’s bedrock states.

There was also the giant $58.8 million Texas Department of Transportation contract from early in July, covering a six lane expansion on over eight miles of Interstate 45, as well as widening of seven existing bridges. Or, the $21.3 million Bailey Road widening project for the Houston suburb of Pearland announced earlier in that same month, secured via the company’s ability to underbid everyone else at the table. For STRL, this is about more than just securing prime contracts in what is a company stronghold, it’s about leveraging the company’s own logistical capacity to create value for its shareholders, laying hands on work that will produce good margins, and whose successful completion will help keep Sterling in the good graces of state and local administrators.

There was little surprise among clued-in analysts when the company beat Q3 estimates handily, delivering a robust set of financials in early November, which showed an adjusted $0.09 earnings per share on the strength of a 10.7 percent year-over-year reduction in the cost of sales. Gross profits were also up markedly for the quarter, showing a 72.6 percent gain to $14.5 million when compared with Q3 FY14’s figures, as well as a 3.8 percent rise in gross margins over the same interval.

For a closer look, visit http://www.strlco.com

Since opening its first location in 2009, Giggles N’ Hugs has leveraged an innovative, award-winning family restaurant concept to promote rapid industry growth. Today, the company owns and operates three locations in and around Los Angeles, and it’s currently working with mall owners to expand this national footprint in the months to come. Last month, GIGL gave prospective shareholders some insight into this process when it revealed negotiations to expand its existing partnership with Westfield Corp. (OTC: WEFIF), one of the largest mall owners and operators in the world, and, potentially, open additional locations in the near future.

“Westfield is thrilled to have Giggles N’ Hugs as a tenant and would like to strengthen our relationship… by having more locations in our shopping centers and airports,” Shannon Westmore, vice president of leasing for Westfield, stated in a news release.

GIGL aims to operate 12 company-owned locations by the end of 2017 while continuing to actively explore franchise opportunities. In addition to expanding its presence in southern California, the company has outlined plans to extend its reach along the West Coast. Earlier this year, GIGL highlighted Seattle and San Francisco as key markets of interest moving forward. The company expects to receive significant discounts from current market rents and attractive tenant allowance on new locations as a result of the early successes of its existing restaurants.

Franchising opportunities could also present GIGL with immense growth potential if and when the company decides to pursue the strategy. In a recent news release, Joey Parsi, founder and chief executive officer of GIGL, stated that the company has received substantial interest from both large multi-unit franchising operators and individual franchisees regarding both domestic and international opportunities. To better assess these opportunities, GIGL expanded its management team to include two executives – John Kaufman and Philip Gay – with extensive experience in the franchising space.

By offering healthy dining options and an exciting atmosphere for families, GIGL is addressing a significant unmet need in the restaurant industry. Look for the company to continue executing on this proven business model as it pursues potentially lucrative expansion opportunities in the form of both company-owned and franchise locations in the coming months.

For more information, visit www.gigglesnhugs.com

Horizon Pharma PLC (NASDAQ: HZNP) is a biopharmaceutical company focused on improving the lives of patients by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs. The company’s portfolio includes four commercialized medications for the treatment of arthritis pain and inflammation – including DUEXIS®, PENNSAID®, RAYOS® and VIMOVO® – as well as three additional products targeting rare diseases – including ACTUMMUNE® for the treatment of chronic granulomatous disease (CGD) and severe, malignant osteopetrosis (SMO), as well as BUPHENYL® and RAVICTI® for the treatment of urea cycle disorders (UCDs).

Through these products, Horizon is addressing a collection of promising indications within the biopharmaceutical industry. According to the Centers for Disease Control and Prevention, one in five adults in the United States, more than 50 million people, report having doctor-diagnosed arthritis, and this figure is expected to expand to include an estimated 67 million American adults by 2030. As the nation’s number one cause of disability, arthritis accounts for more than $156 billion in lost wages and medical expenses annually, including nearly a million hospitalizations.

In a recent news release, Horizon highlighted the market potential of its four arthritis medications when it announced that 2015 net sales for the products exceeded $500 million. This performance was a result of Horizon’s total prescription growth, which has increased by 189 percent since January 2014. The company’s four arthritis pain and inflammation products accounted for 1.5 million total prescriptions, but management is optimistic about the prospects for significant future growth. The U.S. NSAID market, in which DUEXIS, VIMOVO and PENNSAID participate, accounts for roughly 117 million prescriptions each year.

“Since our company’s inception, we have built a strong and diverse portfolio of medicines through best-in-class commercial execution and value-enhancing acquisitions that we expect will drive nearly $1 billion in net sales in 2016,” Timothy P. Walbert, chairman, president and chief executive officer of Horizon, stated in a news release. “As we look to the future, we believe our long-range plan has the potential to double net sales by 2020, led by our rapidly expanding orphan business.”

By 2020, Horizon expects its orphan business unit to represent approximately 60 percent of total company net sales. In support of this goal, Horizon is currently studying ACTIMMUNE in a phase III clinical trial for Friedreich’s ataxia, an inherited disease that causes progressive damage to the nervous system. The company is also preparing to initiate a phase I dosing trial in combination with PD-1/PD-L1 inhibitors for the treatment of various forms of cancer. Based on third quarter 2015 net sales, Horizon forecasts $265 million in annualized U.S. sales for ACTIMMUNE and RAVICTI in 2015.

“We expect to accelerate clinical development of ACTIMMUNE, with a specific focus on Friedreich’s ataxia and cancer,” concluded Walbert.

For prospective shareholders, Horizon’s ongoing progress toward expanding its sales in both its arthritis pain and inflammation products and its orphan disease treatments could foreshadow an opportunity for the company to achieve considerable financial growth in the months to come. Look for Horizon to close in on its 2020 growth goals as it progresses with the clinical development of ACTIMMUNE moving forward.

For more information, visit www.horizonpharma.com